MA

Memon Abdulzahir Gulamnabi

Active Director Director DIN 11505535
DIN 11505535 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Memon Abdulzahir Gulamnabi

Data last updated:

Memon Abdulzahir Gulamnabi is a Director at Shibra Pharma Private Limited (since 2026).

DIN 11505535
Primary Designation Director
First Appointment 27 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shibra Pharma Private Limited U21004GJ2026PTC172599
Director27 Jan 20262026Active

Board colleagues of Memon Abdulzahir Gulamnabi

NameDINCompanyDesignation
Mohseen Rahimbhai Ghanchi11505534Shibra Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shibra Pharma Private Limited
Premium access

Shareholding and investment profile for Memon Abdulzahir Gulamnabi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Memon Abdulzahir Gulamnabi

Memon Abdulzahir Gulamnabi currently holds 1 directorship: Shibra Pharma Private Limited (Director, since 27 Jan 2026).

Memon Abdulzahir Gulamnabi was first appointed on 27 Jan 2026 as Director at Shibra Pharma Private Limited.

The current boards of Memon Abdulzahir Gulamnabi's companies include Mohseen Rahimbhai Ghanchi (Shibra Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available